 | • レポートコード：GIR-107A14810 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、血管内皮増殖因子Bのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。血管内皮増殖因子Bの種類別市場規模（アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他）、用途別市場規模（直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・血管内皮増殖因子Bの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Alteogen Inc、CSL Ltd、Eli Lilly and Company、Formycon AG、Regeneron Pharmaceuticals Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他 ・用途別分析2016年-2026年：直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他 ・血管内皮増殖因子Bの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・血管内皮増殖因子Bのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・血管内皮増殖因子Bのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・血管内皮増殖因子Bの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・血管内皮増殖因子Bの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Vascular Endothelial Growth Factor B market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vascular Endothelial Growth Factor B size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Vascular Endothelial Growth Factor B market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Vascular Endothelial Growth Factor B market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aflibercept
Aflibercept Biosimilar
CSL-346
Others
Market segment by Application can be divided into
Rectal Cancer
Retinal Vein Occlusion
Diabetic Nephropathy
Others
The key market players for global Vascular Endothelial Growth Factor B market are listed below:
Alteogen Inc
CSL Ltd
Eli Lilly and Company
Formycon AG
Regeneron Pharmaceuticals Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Vascular Endothelial Growth Factor B product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vascular Endothelial Growth Factor B, with price, sales, revenue and global market share of Vascular Endothelial Growth Factor B from 2019 to 2021.
Chapter 3, the Vascular Endothelial Growth Factor B competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vascular Endothelial Growth Factor B breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vascular Endothelial Growth Factor B market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Vascular Endothelial Growth Factor B sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Vascular Endothelial Growth Factor B Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vascular Endothelial Growth Factor B Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Aflibercept
1.2.3 Aflibercept Biosimilar
1.2.4 CSL-346
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vascular Endothelial Growth Factor B Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Rectal Cancer
1.3.3 Retinal Vein Occlusion
1.3.4 Diabetic Nephropathy
1.3.5 Others
1.4 Global Vascular Endothelial Growth Factor B Market Size & Forecast
1.4.1 Global Vascular Endothelial Growth Factor B Sales in Value (2016-2026))
1.4.2 Global Vascular Endothelial Growth Factor B Sales in Volume (2016-2026)
1.4.3 Global Vascular Endothelial Growth Factor B Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Vascular Endothelial Growth Factor B Production Capacity Analysis
1.5.1 Global Vascular Endothelial Growth Factor B Total Production Capacity (2016-2026)
1.5.2 Global Vascular Endothelial Growth Factor B Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vascular Endothelial Growth Factor B Market Drivers
1.6.2 Vascular Endothelial Growth Factor B Market Restraints
1.6.3 Vascular Endothelial Growth Factor B Trends Analysis
2 Manufacturers Profiles
2.1 Alteogen Inc
2.1.1 Alteogen Inc Details
2.1.2 Alteogen Inc Major Business
2.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Product and Services
2.1.4 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 CSL Ltd
2.2.1 CSL Ltd Details
2.2.2 CSL Ltd Major Business
2.2.3 CSL Ltd Vascular Endothelial Growth Factor B Product and Services
2.2.4 CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Eli Lilly and Company
2.3.1 Eli Lilly and Company Details
2.3.2 Eli Lilly and Company Major Business
2.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Product and Services
2.3.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Formycon AG
2.4.1 Formycon AG Details
2.4.2 Formycon AG Major Business
2.4.3 Formycon AG Vascular Endothelial Growth Factor B Product and Services
2.4.4 Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Regeneron Pharmaceuticals Inc
2.5.1 Regeneron Pharmaceuticals Inc Details
2.5.2 Regeneron Pharmaceuticals Inc Major Business
2.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product and Services
2.5.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Vascular Endothelial Growth Factor B Sales by Manufacturer
3.1 Global Vascular Endothelial Growth Factor B Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vascular Endothelial Growth Factor B Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vascular Endothelial Growth Factor B
3.4 Market Concentration Rate
3.4.1 Top 3 Vascular Endothelial Growth Factor B Manufacturer Market Share
3.4.2 Top 6 Vascular Endothelial Growth Factor B Manufacturer Market Share
3.5 Global Vascular Endothelial Growth Factor B Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vascular Endothelial Growth Factor B Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vascular Endothelial Growth Factor B Market Size by Region
4.1.1 Global Vascular Endothelial Growth Factor B Sales in Volume by Region (2016-2026)
4.1.2 Global Vascular Endothelial Growth Factor B Revenue by Region (2016-2026)
4.2 North America Vascular Endothelial Growth Factor B Revenue (2016-2026)
4.3 Europe Vascular Endothelial Growth Factor B Revenue (2016-2026)
4.4 Asia-Pacific Vascular Endothelial Growth Factor B Revenue (2016-2026)
4.5 South America Vascular Endothelial Growth Factor B Revenue (2016-2026)
4.6 Middle East and Africa Vascular Endothelial Growth Factor B Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vascular Endothelial Growth Factor B Sales in Volume by Type (2016-2026)
5.2 Global Vascular Endothelial Growth Factor B Revenue by Type (2016-2026)
5.3 Global Vascular Endothelial Growth Factor B Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vascular Endothelial Growth Factor B Sales in Volume by Application (2016-2026)
6.2 Global Vascular Endothelial Growth Factor B Revenue by Application (2016-2026)
6.3 Global Vascular Endothelial Growth Factor B Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vascular Endothelial Growth Factor B Sales by Type (2016-2026)
7.2 North America Vascular Endothelial Growth Factor B Sales by Application (2016-2026)
7.3 North America Vascular Endothelial Growth Factor B Market Size by Country
7.3.1 North America Vascular Endothelial Growth Factor B Sales in Volume by Country (2016-2026)
7.3.2 North America Vascular Endothelial Growth Factor B Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vascular Endothelial Growth Factor B Sales by Type (2016-2026)
8.2 Europe Vascular Endothelial Growth Factor B Sales by Application (2016-2026)
8.3 Europe Vascular Endothelial Growth Factor B Market Size by Country
8.3.1 Europe Vascular Endothelial Growth Factor B Sales in Volume by Country (2016-2026)
8.3.2 Europe Vascular Endothelial Growth Factor B Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vascular Endothelial Growth Factor B Sales by Type (2016-2026)
9.2 Asia-Pacific Vascular Endothelial Growth Factor B Sales by Application (2016-2026)
9.3 Asia-Pacific Vascular Endothelial Growth Factor B Market Size by Region
9.3.1 Asia-Pacific Vascular Endothelial Growth Factor B Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vascular Endothelial Growth Factor B Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vascular Endothelial Growth Factor B Sales by Type (2016-2026)
10.2 South America Vascular Endothelial Growth Factor B Sales by Application (2016-2026)
10.3 South America Vascular Endothelial Growth Factor B Market Size by Country
10.3.1 South America Vascular Endothelial Growth Factor B Sales in Volume by Country (2016-2026)
10.3.2 South America Vascular Endothelial Growth Factor B Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type (2016-2026)
11.2 Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application (2016-2026)
11.3 Middle East & Africa Vascular Endothelial Growth Factor B Market Size by Country
11.3.1 Middle East & Africa Vascular Endothelial Growth Factor B Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vascular Endothelial Growth Factor B Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vascular Endothelial Growth Factor B Typical Distributors
12.3 Vascular Endothelial Growth Factor B Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Vascular Endothelial Growth Factor B Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vascular Endothelial Growth Factor B Revenue by Application, (USD Million), 2021-2026
Table 3. Alteogen Inc Basic Information, Manufacturing Base and Competitors
Table 4. Alteogen Inc Major Business
Table 5. Alteogen Inc Vascular Endothelial Growth Factor B Product and Services
Table 6. Alteogen Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 8. CSL Ltd Major Business
Table 9. CSL Ltd Vascular Endothelial Growth Factor B Product and Services
Table 10. CSL Ltd Vascular Endothelial Growth Factor B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly and Company Major Business
Table 13. Eli Lilly and Company Vascular Endothelial Growth Factor B Product and Services
Table 14. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Formycon AG Basic Information, Manufacturing Base and Competitors
Table 16. Formycon AG Major Business
Table 17. Formycon AG Vascular Endothelial Growth Factor B Product and Services
Table 18. Formycon AG Vascular Endothelial Growth Factor B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 20. Regeneron Pharmaceuticals Inc Major Business
Table 21. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product and Services
Table 22. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Vascular Endothelial Growth Factor B Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 24. Global Vascular Endothelial Growth Factor B Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Vascular Endothelial Growth Factor B, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Vascular Endothelial Growth Factor B Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 27. Head Office and Vascular Endothelial Growth Factor B Production Site of Key Manufacturer
Table 28. Vascular Endothelial Growth Factor B New Entrant and Capacity Expansion Plans
Table 29. Vascular Endothelial Growth Factor B Mergers & Acquisitions in the Past Five Years
Table 30. Global Vascular Endothelial Growth Factor B Sales by Region (2016-2021e) & (K Pcs)
Table 31. Global Vascular Endothelial Growth Factor B Sales by Region (2021-2026) & (K Pcs)
Table 32. Global Vascular Endothelial Growth Factor B Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global Vascular Endothelial Growth Factor B Revenue by Region (2021-2026) & (USD Million)
Table 34. Global Vascular Endothelial Growth Factor B Sales by Type (2016-2021e) & (K Pcs)
Table 35. Global Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (K Pcs)
Table 36. Global Vascular Endothelial Growth Factor B Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (USD Million)
Table 38. Global Vascular Endothelial Growth Factor B Price by Type (2016-2021e) & (USD/Pcs)
Table 39. Global Vascular Endothelial Growth Factor B Price by Type (2021-2026) & (USD/Pcs)
Table 40. Global Vascular Endothelial Growth Factor B Sales by Application (2016-2021e) & (K Pcs)
Table 41. Global Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (K Pcs)
Table 42. Global Vascular Endothelial Growth Factor B Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (USD Million)
Table 44. Global Vascular Endothelial Growth Factor B Price by Application (2016-2021e) & (USD/Pcs)
Table 45. Global Vascular Endothelial Growth Factor B Price by Application (2021-2026) & (USD/Pcs)
Table 46. North America Vascular Endothelial Growth Factor B Sales by Country (2016-2021e) & (K Pcs)
Table 47. North America Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (K Pcs)
Table 48. North America Vascular Endothelial Growth Factor B Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (USD Million)
Table 50. North America Vascular Endothelial Growth Factor B Sales by Type (2016-2021e) & (K Pcs)
Table 51. North America Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (K Pcs)
Table 52. North America Vascular Endothelial Growth Factor B Sales by Application (2016-2021e) & (K Pcs)
Table 53. North America Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (K Pcs)
Table 54. Europe Vascular Endothelial Growth Factor B Sales by Country (2016-2021e) & (K Pcs)
Table 55. Europe Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (K Pcs)
Table 56. Europe Vascular Endothelial Growth Factor B Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe Vascular Endothelial Growth Factor B Sales by Type (2016-2021e) & (K Pcs)
Table 59. Europe Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (K Pcs)
Table 60. Europe Vascular Endothelial Growth Factor B Sales by Application (2016-2021e) & (K Pcs)
Table 61. Europe Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (K Pcs)
Table 62. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Region (2016-2021e) & (K Pcs)
Table 63. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Region (2021-2026) & (K Pcs)
Table 64. Asia-Pacific Vascular Endothelial Growth Factor B Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific Vascular Endothelial Growth Factor B Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Type (2016-2021e) & (K Pcs)
Table 67. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (K Pcs)
Table 68. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Application (2016-2021e) & (K Pcs)
Table 69. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (K Pcs)
Table 70. South America Vascular Endothelial Growth Factor B Sales by Country (2016-2021e) & (K Pcs)
Table 71. South America Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (K Pcs)
Table 72. South America Vascular Endothelial Growth Factor B Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (USD Million)
Table 74. South America Vascular Endothelial Growth Factor B Sales by Type (2016-2021e) & (K Pcs)
Table 75. South America Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (K Pcs)
Table 76. South America Vascular Endothelial Growth Factor B Sales by Application (2016-2021e) & (K Pcs)
Table 77. South America Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (K Pcs)
Table 78. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Country (2016-2021e) & (K Pcs)
Table 79. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (K Pcs)
Table 80. Middle East & Africa Vascular Endothelial Growth Factor B Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa Vascular Endothelial Growth Factor B Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type (2016-2021e) & (K Pcs)
Table 83. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (K Pcs)
Table 84. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application (2016-2021e) & (K Pcs)
Table 85. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (K Pcs)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. Vascular Endothelial Growth Factor B Typical Distributors
Table 89. Vascular Endothelial Growth Factor B Typical Customers
List of Figures
Figure 1. Vascular Endothelial Growth Factor B Picture
Figure 2. Global Vascular Endothelial Growth Factor B Sales Market Share by Type in 2020
Figure 3. Aflibercept
Figure 4. Aflibercept Biosimilar
Figure 5. CSL-346
Figure 6. Others
Figure 7. Global Vascular Endothelial Growth Factor B Sales Market Share by Application in 2020
Figure 8. Rectal Cancer
Figure 9. Retinal Vein Occlusion
Figure 10. Diabetic Nephropathy
Figure 11. Others
Figure 12. Global Vascular Endothelial Growth Factor B Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Vascular Endothelial Growth Factor B Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Vascular Endothelial Growth Factor B Sales (2016-2026) & (K Pcs)
Figure 15. Global Vascular Endothelial Growth Factor B Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Vascular Endothelial Growth Factor B Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Vascular Endothelial Growth Factor B Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Vascular Endothelial Growth Factor B Market Drivers
Figure 19. Vascular Endothelial Growth Factor B Market Restraints
Figure 20. Vascular Endothelial Growth Factor B Market Trends
Figure 21. Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturer in 2020
Figure 22. Global Vascular Endothelial Growth Factor B Revenue Market Share by Manufacturer in 2020
Figure 23. Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Vascular Endothelial Growth Factor B Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Vascular Endothelial Growth Factor B Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2016-2026)
Figure 27. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2016-2026)
Figure 28. North America Vascular Endothelial Growth Factor B Revenue (2016-2026) & (USD Million)
Figure 29. Europe Vascular Endothelial Growth Factor B Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Vascular Endothelial Growth Factor B Revenue (2016-2026) & (USD Million)
Figure 31. South America Vascular Endothelial Growth Factor B Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Vascular Endothelial Growth Factor B Revenue (2016-2026) & (USD Million)
Figure 33. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2016-2026)
Figure 34. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2016-2026)
Figure 35. Global Vascular Endothelial Growth Factor B Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2016-2026)
Figure 37. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2016-2026)
Figure 38. Global Vascular Endothelial Growth Factor B Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Vascular Endothelial Growth Factor B Sales Market Share by Type (2016-2026)
Figure 40. North America Vascular Endothelial Growth Factor B Sales Market Share by Application (2016-2026)
Figure 41. North America Vascular Endothelial Growth Factor B Sales Market Share by Country (2016-2026)
Figure 42. North America Vascular Endothelial Growth Factor B Revenue Market Share by Country (2016-2026)
Figure 43. United States Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Vascular Endothelial Growth Factor B Sales Market Share by Type (2016-2026)
Figure 47. Europe Vascular Endothelial Growth Factor B Sales Market Share by Application (2016-2026)
Figure 48. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country (2016-2026)
Figure 49. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country (2016-2026)
Figure 50. Germany Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Vascular Endothelial Growth Factor B Revenue Market Share by Region (2016-2026)
Figure 59. China Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Vascular Endothelial Growth Factor B Sales Market Share by Type (2016-2026)
Figure 66. South America Vascular Endothelial Growth Factor B Sales Market Share by Application (2016-2026)
Figure 67. South America Vascular Endothelial Growth Factor B Sales Market Share by Country (2016-2026)
Figure 68. South America Vascular Endothelial Growth Factor B Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Vascular Endothelial Growth Factor B Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の低酸素誘導因子1アルファ阻害剤市場 2021：企業別、地域別、種類・用途別 The Hypoxia Inducible Factor 1 Alpha Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…- 世界の抗血友病因子・フォンウィルブランド因子複合体市場 2021：企業別、地域別、種類・用途別 The Antihemophilic Factor & von Willebrand Factor Complex market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 世界の線維芽細胞成長因子2市場 2021：企業別、地域別、種類・用途別 The Fibroblast Growth Factor 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のトランスフォーミング増殖因子β2市場 2021：企業別、地域別、種類・用途別 The Transforming Growth Factor Beta 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の抗血友病因子（組換え）市場 2021：企業別、地域別、種類・用途別 The Antihemophilic Factor (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…